Back to search

Article

A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic Medications

2026-07-03

Abstract excerpt

<title>Abstract</title> <p>China’s Volume-Based Procurement (VBP) has attracted enormous interest in health policy owing to its profound effects on reducing drug costs and reshaping the pharmaceutical market.However, the heterogeneous impacts of VBP on the gastrointestinal and metabolic medications market remain poorly understood. As a major therapeutic category, gastrointestinal and metabolic medications play a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dbd9726a-3bdd-5d49-bb46-3e4283904762
DOI
10.21203/rs.3.rs-10070440/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsDOI 10.21203/rs.3.rs-10070440/v1
The impact of the national centralized drug procurement on the use of original and generic targeted anti- tumor drugs in Hohhot, China: an interrupted time-series analysisSemantic proximity
Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity
Effects of volume-based procurement policy on the usage and expenditure of first-generation targeted drugs for non-small cell lung cancer with EGFR mutation in China: an interrupted time series study.Semantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national databaseSemantic proximity
When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-ThroughSemantic proximity
Analysis and Solutions for Drug Shortages in Multi-level Medical Institutions in China: References for Developing CountriesSemantic proximity
Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in TaiwanSemantic proximity
Impact of Generic Antiretroviral Drugs Introduction on Pharmaceutical Expenditure Patterns in the Netherlands: A Six-Year Retrospective Database Analysis from 2016 to 2022Semantic proximity
A Case of Excessive, Opportunistic Price Increase of a Generic Oncology DrugSemantic proximity
What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity
The Economic Impact of National Essential Public Health Service Package for Hypertension and Type-2 Diabetes: A Retrospective Province-wide Study in ChinaSemantic proximity
Select a neighboring publication to make it the new centre.